| First Author | Richard EM | Year | 2023 |
| Journal | Cell Death Dis | Volume | 14 |
| Issue | 6 | Pages | 387 |
| PubMed ID | 37386014 | Mgi Jnum | J:342760 |
| Mgi Id | MGI:7494585 | Doi | 10.1038/s41419-023-05912-y |
| Citation | Richard EM, et al. (2023) Wfs1(E864K) knock-in mice illuminate the fundamental role of Wfs1 in endocochlear potential production. Cell Death Dis 14(6):387 |
| abstractText | Wolfram syndrome (WS) is a rare neurodegenerative disorder encompassing diabetes mellitus, diabetes insipidus, optic atrophy, hearing loss (HL) as well as neurological disorders. None of the animal models of the pathology are presenting with an early onset HL, impeding the understanding of the role of Wolframin (WFS1), the protein responsible for WS, in the auditory pathway. We generated a knock-in mouse, the Wfs1(E864K) line, presenting a human mutation leading to severe deafness in affected individuals. The homozygous mice showed a profound post-natal HL and vestibular syndrome, a collapse of the endocochlear potential (EP) and a devastating alteration of the stria vascularis and neurosensory epithelium. The mutant protein prevented the localization to the cell surface of the Na(+)/K(+)ATPase beta1 subunit, a key protein for the maintenance of the EP. Overall, our data support a key role of WFS1 in the maintenance of the EP and the stria vascularis, via its binding partner, the Na(+)/K(+)ATPase beta1 subunit. |
